Abstract
Background
Twenty cases of invasive ductal carcinoma of the breast with a pure or partial glycogenrich clear cell carcinoma (GRCC) component are reported. GRCC of the breast is composed almost entirely of polygonal cells with clear cytoplasm. These contain large amounts of partly water-soluble glycogen.
Methods
The cases were analyzed using various parameters, including age at presentation, tumor size, tumor grade, axillary lymph node and Her2/neu status.
Results
Between 1990 and 2004, 723 patients with primary breast carcinomas were treated and clinicopathologic analysis was performed. 20 cases were identified as GRCC among the 723 cases. The patients’ age at presentation ranged from 33 to 68 years (mean, 52 years). Tumor size ranged from 1 to 6.5 cm (mean, 2.6 cm); 35% (7 of 20) of cases that underwent axillary dissection had positive lymph nodes. Among 15 of 20 cases who were followed for 1–72 months, 5 cases died from their breast carcinoma within 5 years following the diagnosis.
Conclusion
Our series included more small size carcinomas than did previous series. Lymph node status does not appear to be markedly different from that of the usual invasive ductal carcinomas. Her2/neu expression was similar to that found in common breast carcinomas.
Similar content being viewed by others
References
Fisher ER, Tavares J, Bulatao IS, Sass R, Fisher B: Glycogen-rich clear cell breast cancer: with comments concerning other clear cell variants.Hum Pathol 16: 1085–1090, 1985.
Toikkanen S, Joensuu H: Glycogen-rich clear cell carcinoma of the breast: a clinicopathologic and flow cytometric study.Hum Pathol 22: 81–83, 1991.
Hull MT, Warfel KA: Glycogen-rich clear cell carcinomas of the breast. A clinicopathologic and ultrastructural study.Am J Surg Patho 10: 553–559, 1986.
Sorensen FB, Paulsen SM: Glycogen rich clear cell carcinoma of the breast: a solid variant with mucus. A light microscopic, immunohistochemical and ultrastructural study of a case.Histopathology 11: 857–869, 1987.
Hull MT, Priest JB, Broadie TA, Ransburg RC, McCarthy LJ: Glycogen-rich clear cell carcinoma of the breast: a light and electron microscopic study.Cancer 48: 2003–2009, 1981.
Haye MM, Sedman JD, Ashton MA: Glycogen-rich clear cell carcinoma of the breast. A clinicopathologic study of 21 cases.Am J Surg Pathol 19: 904–911, 1995.
Di Tommaso L, Pasquinelli G, Portincasa G, Santini D: Glycogen-rich clear cell breast carcinoma with neuroendocrine differentiation features.Pathologica 93: 676–680, 2001.
Shirley SE, Escoffery CT, Titus IP, Williams EE, West AB: Clear cell carcinoma of the breast with immunohistochemical evidence of divergent differentiation.Ann Diagn Pathol 6: 250–256, 2002.
Aboumrad MH, Horn RC, Fine G: Lipid-secreting mammary carcinoma: Report of a case associated with Paget’s disease of the nipple.Cancer 16: 521–525, 1963.
Ramous CV, Taylor HB: Lipid-rich carcinoma of the breast: A clinicopathological analysis of thirteen examples.Cancer 33: 812–819, 1974.
Akhtar M, Robinson C, Ali MA, Godwin JT: Secretory carcinoma of the breast in adults: Light and electron microscopic study of three cases with review of the literature.Cancer 51: 2245–2254, 1983.
Sullivan JJ, Magee HR, Donald KJ: Secretory (juvenile) carcinoma of the breast.Pathology 9: 341–346, 1977.
Merino MJ, Livolsi VA: Signet ring cell carcinoma of the female breast: A clinico-pathologic analysis of 24 cases.Cancer 48: 1830–1837, 1981.
Mohamed AH, Cherrick HM: Glycogen-rich adenocarcinoma of minor salivary glands: A light and electron microscopic study.Cancer 36: 1057–1066, 1975.
Herbest AL, Scully RE: Adenocarcinoma of the vagina in adolescence: a report of 7 cases including 6 clearcell carcinomas (so-called mesonephromas).Cancer 25: 745–747, 1970.
Roth LM: Clear-cell adenocarcinoma of the female genital tract: A light and electron microscopic study.Cancer 33: 990–1001, 1974.
Morgan AD, Mackenzie DH: Clear-cell carcinoma of the lung.J Pathol Bacteriol 87: 25–27, 1964.
Seo IS, Tomich CE, Hull MT, Warfel KA: Clear cell carcinoma of the larynx: A variant of mucoepidermoid carcinoma.Ann Otol Rhinol Laryngol 89: 168–172, 1980.
Sliverberg SG: Ultrastructure and histogenesis of clear cell carcinoma of the ovary.Am J Obstet Gynecol 115: 394–400, 1973.
Benisch B, Peison B, Newman R, Sobel HJ, Marquet E: Solid glycogen-rich clear cell carcinoma of the breast (a light and ultrastructural study).Am J Clin Pathol 79: 319–328, 1983.
Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P: Overexpression of HER2/neu is associated with poor survival in advanced epithelial ovarian cancer.Cancer Res 50: 4087–4091, 1990.
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER- 2/neu oncogene.Science 235: 177–182, 1987.
Zhang X, Silva E, Gershenson D, Hung MC: Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.Oncogene 4: 985–989, 1989.
Schneider PM, Hung MC, Chiocca SM, Manning J, Zhao XY, Fang K, Roth JA: Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.Cancer Res 49: 4968–4971, 1989.
Yoshida K, Tsuda T, Matsumura T, Tsujino T, Hattori T, Ito H, Tahara E: Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas.Virchows Arch 57: 285–290, 1989.
Lovekin C, Ellis IO, Locker A, Robertson JF, Bell J, Nicholson R, Gullick WJ, Elston CW, Blarney RW: Cerb-2 oncoprotein expression in primary and advanced breast cancer. Erratum in:Br J Cancer 63: 439- 443, 1991.
De Potter CR, Van Daele S, Van de Vijver MJ, Pauwels C, Maertens G, De Boever J, Vandekerckhove D, Roels H: The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues.Histopathology 15: 351–362, 1989.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kuroda, H., Sakamoto, G., Ohnisi, K. et al. Clinical and pathological features of glycogen-rich clear cell carcinoma of the breast. Breast Cancer 12, 189–195 (2005). https://doi.org/10.2325/jbcs.12.189
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.2325/jbcs.12.189